SlowBull
The Business Brief MONDAY, 24 AUGUST 2026
← All stories
Markets

GSK wins Japan approval for hepatitis B drug, gets FDA review

1 source ·2 articles ·2h ago GSK

Covered by 1 outlet

Investing 2

All coverage · 2 articles

Investing.com Canada ·2h ago

GSK wins Japan approval for hepatitis B drug, gets FDA review

Investing.com Stock Market ·2h ago

GSK wins Japan approval for hepatitis B drug, gets FDA review